Fischer Medical Ventures Ltd — Results, 28-05-2025: Result

Fischer Medical Ventures Limited has announced a board meeting outcome approving and taking on record the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2025, with an unmodified auditor opinion from M/s. Bilimoria Mehta & Co. The company reported consolidated revenue from operations of ₹110.70 Cr and a profit after tax of ₹1.21 Cr for the year. On a standalone basis, revenue was ₹5.22 Cr with a loss of ₹0.89 Cr. The board has proposed a final dividend of ₹0.05 per share, subject to shareholder approval. It approved the re-appointment of auditors for a second five-year term and appointed S. Ramanand Aiyer & Co. as internal auditors for FY26. The company also recommended listing on the NSE main board. Several new subsidiaries were incorporated and consolidated during the year, expanding the group’s footprint. The healthy revenue growth and positive consolidated profitability reflect operational scale-up, while the recommended dividend and new auditor appointments signify governance continuity.